Prospective clinical assessment of morbidity after chin bone harvest.

J Craniofac Surg

Division of Oral and Maxillofacial Surgery, Piracicaba Dental School, State University of Campinas, Campinas, São Paulo, Brazil.

Published: November 2011

The aim of this prospective research was to assess soft tissue morbidity in the symphyseal region after bone graft harvesting. Thirty patients, with average age 45 years, underwent symphyseal bone graft harvesting followed up for a period of 12 months. Follow-up involved neurosensory testing of 2-point discrimination, static light touch, brush directional stroke, pinprick, and thermal discrimination to cold and hot; the statistical analysis was performed using McNemar test and Friedman test with P < 0.05. The results showed that 50% of patients had postoperative morbidity in the first month after surgery showing statistical positive relation with surgery (P < 0.05); at 6 months, this situation diminished to 23%, and at the end of the monitoring period (1 year); the neurosensory tests revealed no persistent morbidity. In conclusion, all neurosensory tests revealed high morbidity in the first month with total resolutions at 1-year follow-up; however, this complication associated to surgery is indispensable to discharge the patient properly.

Download full-text PDF

Source
http://dx.doi.org/10.1097/SCS.0b013e3182326f69DOI Listing

Publication Analysis

Top Keywords

bone graft
8
graft harvesting
8
morbidity month
8
neurosensory tests
8
tests revealed
8
morbidity
5
prospective clinical
4
clinical assessment
4
assessment morbidity
4
morbidity chin
4

Similar Publications

Background: Autologous osteochondral transplantation (AOT) is an option to treat large osteochondral lesions of the talus (OLTs), accompanying subchondral cyst, and previous unsuccessful bone marrow stimulation (BMS) procedures. Although there is extensive literature on the outcomes of surgical interventions for medial osteochondral lesions, research focusing on lateral lesions remains limited. This article presents the intermediate-term clinical and radiologic outcomes following AOT for lateral OLTs.

View Article and Find Full Text PDF

Background/aims: Bruise is the extravasation of blood that may be mild or severe. Bone marrow mesenchymal stem cells (BM-MSCs) are one of the most promising cells used in regenerative medicine for treating many disorders. We aimed to evaluate the efficiency of BM-MSCs in treating cutaneous bruises.

View Article and Find Full Text PDF

[Clinical characteristics and prognosis of acute erythroleukemia in children].

Zhongguo Dang Dai Er Ke Za Zhi

January 2025

Department of Children's Hematology and Oncology, First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.

Objectives: To investigate the clinical characteristics and prognosis of acute erythroleukemia (AEL) in children.

Methods: A retrospective analysis was conducted on the clinical data, treatment, and prognosis of 8 children with AEL treated at the First Affiliated Hospital of Zhengzhou University from January 2013 to December 2023.

Results: Among the 7 patients with complete bone marrow morphological analysis, 4 exhibited trilineage dysplasia, with a 100% incidence of erythroid dysplasia (7/7), a 71% incidence of myeloid dysplasia (5/7), and a 57% incidence of megakaryocytic dysplasia (4/7).

View Article and Find Full Text PDF

Venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), continues to pose significant clinical challenges despite advancements in medical care. Artificial intelligence (AI) presents promising opportunities to enhance the diagnosis, prediction, and management of VTE. This review examines the transformative potential of AI in thrombosis care, highlighting both the potential benefits and the challenges that need to be addressed.

View Article and Find Full Text PDF

Musculoskeletal complications in sickle cell disease: Pathophysiology, diagnosis and management.

Best Pract Res Clin Rheumatol

January 2025

ICMR-National Institute of Research in Tribal Health, Jabalpur, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India; Model Rural Health Research Unit, Jheet, Durg, India. Electronic address:

Sickle cell disease (SCD) is a mono-genic disorder causing chronic hemolysis, anemia, and vaso-occlusion, leading to musculoskeletal complications such as osteonecrosis, osteoporosis, and bone fractures affecting 50-70% SCD patients. These complications result from a complex interplay of genetic and physiological factors, including abnormal hemoglobin production, chronic inflammation, and oxidative stress. This review discusses the pathophysiology, pre-clinical symptoms, and clinical manifestations of musculoskeletal complications in SCD, as well as current treatment options, including pharmacological interventions, surgical procedures, and bone marrow transplantation.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!